by GV Team | Apr 20, 2020 | Coronavirus, Drug Information, GrandView News, Patient Safety
Blog by Mark Wolfe, Customer Account Representative, GrandView Pharmacy Due to the Covid19 crisis GrandView Pharmacy has had to alter some of our normal, usual and customary policy and procedures. One area of policy and procedures that has caused a bit of confusion...
by GV Team | Apr 16, 2020 | Coronavirus, Drug Information, Messages from CEO, Patient Safety, Resources
Article by TRC, Pharmacists Letter Posted April 3, 2020: Article in Progress. We’re releasing this article ahead of our May 2020 issue to quickly provide information to our readers. The information contained in this version is based on the best evidence available to...
by GV Team | Feb 19, 2020 | Drug Information, Patient Safety, Psychotropic Medications, Regulation Changes, Resources, Senior Health
Article by Jill Murphy, Pharmacy Times “The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule and the Advance Notice Part II to further advance the agency’s efforts to strengthen and modernize the Medicare Advantage and Part D...
by GV Team | Feb 5, 2020 | Drug Information, Patient Safety, Regulation Changes, Resources, Senior Health
Article by Rachel Nania, AARP “President Trump and the contenders seeking to replace him in the White House have all pledged to lower prescription drug prices. But one medication, in particular, is taking center stage in the race for office: insulin. Even though...
by GV Team | Jan 22, 2020 | Drug Information, Patient Safety, Resources, Senior Health
Blog by Mark Wolfe, Customer Account Representative, GrandView Pharmacy Lately it seems that many Assisted Living facilities are asking for help in disposing expired, outdated or discontinued medications that their assisted living and independent living residents...
by GV Team | Jan 20, 2020 | Drug Information, Messages from CEO, Patient Safety, Resources
Article by American Family Physician, www.aafp.org The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (i.e., at least 65 years of age), originally developed by Mark H. Beers in 1991, continue to be used by the American Geriatrics Society...
